You Can’t Patent LSD

Motley Fool Money

Mary Long caught up with Motley Fool Contributor Keith Speights to check in on the psychedelic industry. They discuss:  

- Advice to investors looking at a highly speculative industry.

- The cash and regulatory questions for these companies. 

- Key differences between the cannabis market and psychedelic stocks.

- The challenges of doing a double-blind test on psychedelic compounds.


Companies discussed: CMPS, CYBN, ATAI


Host: Mary Long

Guest: Keith Speights

Producer: Ricky Mulvey 

Engineers: Rick Engdahl, Desireé Jones

Learn more about your ad choices. Visit megaphone.fm/adchoices

2024-11-23 24 min

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.